KURA ONCOLOGY, INC. Debt Instrument, Unamortized Discount
KURA ONCOLOGY, INC. (KURA) had Debt Instrument, Unamortized Discount of $300.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscount · last filed 2026-03-05
- 2025-12-31: Debt Instrument, Unamortized Discount $300.00K.
- 2024-12-31: Debt Instrument, Unamortized Discount $477.00K.
- 2023-12-31: Debt Instrument, Unamortized Discount $668.00K.
- 2022-12-31: Debt Instrument, Unamortized Discount $842.00K.
| Period end | Debt Instrument, Unamortized Discount |
|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-03-05 |
| 2024-12-31 | $477.00K 10-K · filed 2025-02-28 |
| 2023-12-31 | $668.00K 10-K · filed 2024-02-27 |
| 2022-12-31 | $842.00K 10-K · filed 2023-02-23 |
| 2017-12-31 | $402.00K 10-K · filed 2018-03-12 |
| 2017-09-30 | $458.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $145.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $161.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $176.00K 10-K · filed 2017-03-14 |
| 2016-09-30 | $192.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $208.00K 10-Q · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |